SG Americas Securities LLC decreased its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 66.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,723 shares of the oil and gas company's stock after selling 46,017 shares during the period. SG Americas Securities LLC owned approximately 0.05% of Core Laboratories worth $411,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of CLB. Nisa Investment Advisors LLC lifted its stake in shares of Core Laboratories by 2,688.5% in the fourth quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock valued at $42,000 after buying an additional 2,339 shares during the period. Ridgewood Investments LLC lifted its position in shares of Core Laboratories by 4.6% in the 4th quarter. Ridgewood Investments LLC now owns 32,612 shares of the oil and gas company's stock worth $565,000 after acquiring an additional 1,428 shares during the period. Confluence Investment Management LLC grew its holdings in shares of Core Laboratories by 0.4% during the 4th quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company's stock worth $2,360,000 after purchasing an additional 599 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Core Laboratories by 5.8% during the third quarter. JPMorgan Chase & Co. now owns 41,281 shares of the oil and gas company's stock valued at $765,000 after purchasing an additional 2,267 shares during the period. Finally, Tidal Investments LLC raised its stake in shares of Core Laboratories by 1.7% in the third quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company's stock valued at $813,000 after purchasing an additional 716 shares in the last quarter. Institutional investors own 97.81% of the company's stock.
Core Laboratories Price Performance
Shares of NYSE:CLB traded down $1.14 on Thursday, hitting $16.70. The stock had a trading volume of 392,007 shares, compared to its average volume of 311,504. The firm's 50 day moving average price is $18.57 and its 200-day moving average price is $19.25. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $25.13. The company has a market capitalization of $784.25 million, a price-to-earnings ratio of 25.31, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38.
Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting analysts' consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. On average, equities research analysts predict that Core Laboratories Inc. will post 0.96 earnings per share for the current year.
Core Laboratories Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Monday, February 10th will be paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date is Monday, February 10th. Core Laboratories's dividend payout ratio is currently 6.06%.
Analyst Ratings Changes
Several brokerages have issued reports on CLB. Citigroup lowered their price target on shares of Core Laboratories from $15.00 to $14.00 and set a "sell" rating on the stock in a report on Thursday, October 31st. StockNews.com raised shares of Core Laboratories from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $17.00.
View Our Latest Report on CLB
Core Laboratories Profile
(
Free Report)
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Further Reading
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
